Muscle Meds Performance Technologies - Close Out Letter 4/19/15
- Muscle Meds Performance Technologies
Department of Health and Human Services
|Public Health Service|
|Food and Drug Administration|
5100 Paint Branch Parkway
College Park, MD 20740
Craig R. Larsen, Esq.
Legal & Regulatory Affairs
MuscleMeds Performance Technologies
163 East Main Street, Suite 324
Little Falls, NJ 07424
Dear Mr. Larsen:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter dated April 24, 2012. Based on our review, it appears that you have addressed the violations contained in this Warning Letter. Future FDA assessments and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act (the Act) and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent review of your web sites or through other means.
Latasha A. Robinson
Labeling and Dietary Supplement
Center for Food Safety
and Applied Nutrition